| Revisiting the role of neurotransmitters in epilepsy: An updated review E Akyuz, AK Polat, E Eroglu, I Kullu, E Angelopoulou, YN Paudel Life sciences 265, 118826, 2021 | 146 | 2021 |
| Inflammatory mediators of cytokines and chemokines in sepsis: From bench to bedside Z Doganyigit, E Eroglu, E Akyuz Human & Experimental Toxicology 41, 09603271221078871, 2022 | 35 | 2022 |
| Myocardial iron overload in an experimental model of sudden unexpected death in epilepsy E Akyuz, Z Doganyigit, E Eroglu, F Moscovicz, A Merelli, A Lazarowski, ... Frontiers in neurology 12, 609236, 2021 | 20 | 2021 |
| Envisioning the crosstalk between environmental enrichment and epilepsy: A novel perspective E Akyuz, E Eroglu Epilepsy & Behavior 115, 107660, 2021 | 10 | 2021 |
| Immunoreactive definition of TNF-α, HIF-1 α, Kir6. 2, Kir3. 1 and M2 muscarinic receptor for cardiac and pancreatic tissues in a mouse model for type 1 diabetes A Okan, Z Doğanyiğit, E Eroğlu, E Akyüz, N Demir Life Sciences 284, 119886, 2021 | 9 | 2021 |
| The effect of antioxidants in Ehrlich Ascites Cancer S Yılmaz, A Tokpınar, E Eroğlu, Ş Ateş, R Zahid, S Avnioğlu, Ö Bozkurt, ... Cellular and Molecular Biology 67 (2), 20-24, 2021 | 3 | 2021 |
| AN EXPERIMENTAL STUDY ON FOCUS USING ARDUINO SOFTWARE WITH TGAM EEG SENSOR İ Karaman, E Eroğlu INTERNATIONAL ANKARA SCIENTIFIC RESEARCH CONGRESS VIII, 2023 | 1 | 2023 |
| Tauroursodeoxycholic Acid (TUDCA) regulates inflammation and hypoxia in autonomic tissues of rats with seizures AK Üner, A Okan, E Akyüz, B Köklü, E Eroğlu, S Yilmaz, D Ünalmiş, ... Cellular and Molecular Biology 68 (12), 104-111, 2022 | 1 | 2022 |
| Intermediate filament proteins are reliable immunohistological biomarkers to help diagnose multiple tissue‐specific diseases Z Doganyigit, E Eroglu, A Okan Anatomia, Histologia, Embryologia 52 (5), 655-672, 2023 | | 2023 |
| Immunoreactivity of NOS2 and NF-κB in Kidney Tissue in Experimental Alcohol Consumption Model A Okan, AC Uğuz, O Öztürk, E Eroğlu, S Yılmaz, Z Doğanyiğit Journal of Ankara Medicine Faculty, 2023 | | 2023 |
